A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome-Reference-Cited by-同舟云学术

A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome

Published:2007-09-03 Issue:5 Volume:100 Page:1015-1020
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Nielsen Matthew E.,Palapattu Ganesh S.,Karakiewicz Pierre I.,Lotan Yair,Bastian Patrick J.,Lerner Seth P.,Sagalowsky Arthur I.,Schoenberg Mark P.,Shariat Shahrokh F.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2007.07132.x/fullpdf

Reference9 articles.

1. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma;Sanchez-Ortiz;J Urol,2003

2. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage;Chang;J Urol,2003

3. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder;May;Scand J Urol Nephrol,2004

4. Delay in treating bladder tumours;Wallace;Lancet,1965

5. Presenting symptoms, treatment delay and survival in bladder cancer;Mommsen;Scand J Urol Nephrol,1983

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the time of surgical delay on survival in patients with muscle-invasive bladder cancer;Frontiers in Oncology;2022-12-08

2. A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyond;Frontiers in Surgery;2022-10-04

3. Adverse pathological outcomes of patients with de novo muscle invasive bladder cancer in Northern Ontario;Archivio Italiano di Urologia e Andrologia;2022-03-29

4. Impact of noninvasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy on bladder-sparing strategy in patients with muscle-invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2021-02

5. Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy;Clinical Genitourinary Cancer;2021-02